Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Knutson CG"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Offeddu GS; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., Cambria E; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., Shelton SE; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., Haase K; European Molecular Biology Laboratory, European Molecular Biology Laboratory Barcelona, Barcelona, 08003, Spain., Wan Z; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., Possenti L; LaBS, Department of Chemistry, Materials and Chemical Engineering, Politecnico di Milano, Milan, 20133, Italy.; Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, 20133, Italy., Nguyen HT; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA., Gillrie MR; Department of Medicine, Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, T2N 2T9, Canada., Hickman D; Amgen Research, Amgen Inc., 360 Binney Street, Cambridge, MA, 02142, USA., Knutson CG; Amgen Research, Amgen Inc., 360 Binney Street, Cambridge, MA, 02142, USA., Kamm RD; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
Publikováno v:
Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Oct; Vol. 11 (38), pp. e2402757. Date of Electronic Publication: 2024 Jul 23.
Autor:
Claas AM; Biomedical Research, Novartis, Cambridge, Massachusetts, USA., Lee M; Biomedical Research, Novartis, Cambridge, Massachusetts, USA., Huang PH; Biomedical Research, Novartis, East Hanover, New Jersey, USA., Knutson CG; Biomedical Research, Novartis, Cambridge, Massachusetts, USA., Bullara D; Biomedical Research, Novartis, Cambridge, Massachusetts, USA., Schoeberl B; Biomedical Research, Novartis, Cambridge, Massachusetts, USA., Gaudet S; Biomedical Research, Novartis, Cambridge, Massachusetts, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Sep; Vol. 116 (3), pp. 757-769. Date of Electronic Publication: 2024 Apr 26.
Autor:
Kingsley J; Centricity Research (formerly IACT Health), Columbus, Georgia, USA., Kumarasamy N; VHS Infectious Diseases Medical Centre, Chennai Antiviral Research and Treatment Clinical Research Site, Chennai, India., Abrishamian L; South Bay Clinical Research Institute, Redondo Beach, California, USA., Bonten M; Department of Epidemiology & Health Economics, University Medical Center Utrecht, Utrecht, The Netherlands., Igbinadolor A; Monroe Biomedical Research, Monroe, North Carolina, USA., Mekebeb-Reuter M; Excellentis Clinical Trial Consultants, George, South Africa., Rosa J; Clinresco Centres, Gauteng, South Africa., Solai Elango D; Novartis Global Health, Global Drug Development, Hyderabad, India., Lopez P; Novartis Global Health, Novartis Pharma AG, Basel, Switzerland., Fustier P; Molecular Partners AG, Zurich-Schlieren, Switzerland., Goncalves S; Novartis Global Health, Novartis Pharma AG, Basel, Switzerland., Knutson CG; Novartis Global Health, Biomedical Research, Cambridge, Massachusetts, USA., Kukkaro P; Novartis Global Health, Novartis Pharma AG, Basel, Switzerland., Legenne P; Molecular Partners AG, Zurich-Schlieren, Switzerland., Ramanathan K; Novartis Global Health, Novartis Pharma AG, Basel, Switzerland., Rao S; Novartis Global Health, Global Drug Development, East Hanover, New Jersey, USA., Reshetnyak E; Novartis Global Health, Global Drug Development, East Hanover, New Jersey, USA., Stavropoulou V; Molecular Partners AG, Zurich-Schlieren, Switzerland., Stojcheva N; Molecular Partners AG, Zurich-Schlieren, Switzerland., Stumpp MT; Molecular Partners AG, Zurich-Schlieren, Switzerland., Tietz A; Novartis Global Health, Novartis Pharma AG, Basel, Switzerland., Soergel M; Molecular Partners AG, Zurich-Schlieren, Switzerland., Chandra R; Novartis Global Health, Global Drug Development, East Hanover, New Jersey, USA.
Publikováno v:
Open forum infectious diseases [Open Forum Infect Dis] 2024 May 03; Vol. 11 (6), pp. ofae233. Date of Electronic Publication: 2024 May 03 (Print Publication: 2024).
Autor:
Rothenberger S; Spiez Laboratory, Austrasse, Spiez, Switzerland.; Institute of Microbiology, University Hospital Center and University of Lausanne, Lausanne, Switzerland., Hurdiss DL; Department Biomolecular Health Sciences, Division Infectious Diseases & Immunology - Virology section, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.; Cryo-Electron Microscopy, Bijvoet Center for Biomolecular Research, Department of Chemistry, Faculty of Science, Utrecht University, Utrecht, Netherlands., Walser M; Molecular Partners AG, Zurich-Schlieren, Switzerland., Malvezzi F; Molecular Partners AG, Zurich-Schlieren, Switzerland., Mayor J; Spiez Laboratory, Austrasse, Spiez, Switzerland.; Institute of Microbiology, University Hospital Center and University of Lausanne, Lausanne, Switzerland., Ryter S; Spiez Laboratory, Austrasse, Spiez, Switzerland., Moreno H; Institute of Microbiology, University Hospital Center and University of Lausanne, Lausanne, Switzerland., Liechti N; Spiez Laboratory, Austrasse, Spiez, Switzerland., Bosshart A; Molecular Partners AG, Zurich-Schlieren, Switzerland., Iss C; Molecular Partners AG, Zurich-Schlieren, Switzerland., Calabro V; Molecular Partners AG, Zurich-Schlieren, Switzerland., Cornelius A; Molecular Partners AG, Zurich-Schlieren, Switzerland., Hospodarsch T; Molecular Partners AG, Zurich-Schlieren, Switzerland., Neculcea A; Molecular Partners AG, Zurich-Schlieren, Switzerland., Looser T; Molecular Partners AG, Zurich-Schlieren, Switzerland., Schlegel A; Molecular Partners AG, Zurich-Schlieren, Switzerland., Fontaine S; Molecular Partners AG, Zurich-Schlieren, Switzerland., Villemagne D; Molecular Partners AG, Zurich-Schlieren, Switzerland., Paladino M; Molecular Partners AG, Zurich-Schlieren, Switzerland., Schiegg D; Molecular Partners AG, Zurich-Schlieren, Switzerland., Mangold S; Molecular Partners AG, Zurich-Schlieren, Switzerland., Reichen C; Molecular Partners AG, Zurich-Schlieren, Switzerland., Radom F; Molecular Partners AG, Zurich-Schlieren, Switzerland., Kaufmann Y; Molecular Partners AG, Zurich-Schlieren, Switzerland., Schaible D; Molecular Partners AG, Zurich-Schlieren, Switzerland., Schlegel I; Molecular Partners AG, Zurich-Schlieren, Switzerland., Zitt C; Molecular Partners AG, Zurich-Schlieren, Switzerland., Sigrist G; Molecular Partners AG, Zurich-Schlieren, Switzerland., Straumann M; Molecular Partners AG, Zurich-Schlieren, Switzerland., Wolter J; Molecular Partners AG, Zurich-Schlieren, Switzerland., Comby M; Molecular Partners AG, Zurich-Schlieren, Switzerland., Sacarcelik F; Molecular Partners AG, Zurich-Schlieren, Switzerland., Drulyte I; Materials and Structural Analysis, Thermo Fisher Scientific, Eindhoven, Netherlands., Lyoo H; Department Biomolecular Health Sciences, Division Infectious Diseases & Immunology - Virology section, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands., Wang C; Department Biomolecular Health Sciences, Division Infectious Diseases & Immunology - Virology section, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands., Li W; Department Biomolecular Health Sciences, Division Infectious Diseases & Immunology - Virology section, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands., Du W; Department Biomolecular Health Sciences, Division Infectious Diseases & Immunology - Virology section, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands., Binz HK; Binz Biotech Consulting, Zug, Switzerland., Herrup R; Laboratory of Immunoregulation, Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Lusvarghi S; Laboratory of Immunoregulation, Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Neerukonda SN; Laboratory of Immunoregulation, Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Vassell R; Laboratory of Immunoregulation, Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Wang W; Laboratory of Immunoregulation, Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Adler JM; Freie Universität Berlin, Institut für Virologie, Berlin, Germany., Eschke K; Freie Universität Berlin, Institut für Virologie, Berlin, Germany., Nascimento M; Freie Universität Berlin, Institut für Virologie, Berlin, Germany., Abdelgawad A; Freie Universität Berlin, Institut für Virologie, Berlin, Germany., Gruber AD; Freie Universität Berlin, Institut für Tierpathologie, Berlin, Germany., Bushe J; Freie Universität Berlin, Institut für Tierpathologie, Berlin, Germany., Kershaw O; Freie Universität Berlin, Institut für Tierpathologie, Berlin, Germany., Knutson CG; Novartis Institutes for BioMedical Research, PK Sciences, Cambridge, MA, USA., Balavenkatraman KK; Novartis Institutes for BioMedical Research, Preclinical Safety, Basel, Switzerland., Ramanathan K; Novartis Pharma AG, Basel, Switzerland., Wyler E; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Teixeira Alves LG; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Lewis S; Molecular Partners AG, Zurich-Schlieren, Switzerland., Watson R; Molecular Partners AG, Zurich-Schlieren, Switzerland., Haeuptle MA; Molecular Partners AG, Zurich-Schlieren, Switzerland., Zürcher A; Molecular Partners AG, Zurich-Schlieren, Switzerland., Dawson KM; Molecular Partners AG, Zurich-Schlieren, Switzerland., Steiner D; Molecular Partners AG, Zurich-Schlieren, Switzerland., Weiss CD; Laboratory of Immunoregulation, Division of Viral Products, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Amstutz P; Molecular Partners AG, Zurich-Schlieren, Switzerland., van Kuppeveld FJM; Department Biomolecular Health Sciences, Division Infectious Diseases & Immunology - Virology section, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands., Stumpp MT; Molecular Partners AG, Zurich-Schlieren, Switzerland. info@molecularpartners.com., Bosch BJ; Department Biomolecular Health Sciences, Division Infectious Diseases & Immunology - Virology section, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands., Engler O; Spiez Laboratory, Austrasse, Spiez, Switzerland., Trimpert J; Freie Universität Berlin, Institut für Virologie, Berlin, Germany.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2022 Dec; Vol. 40 (12), pp. 1845-1854. Date of Electronic Publication: 2022 Jul 21.
Autor:
Rajczewski AT; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA., Han Q; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA., Mehta S; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA., Kumar P; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA., Jagtap PD; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA., Knutson CG; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Fox JG; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Tretyakova NY; Department of Medicinal Chemistry, the Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA., Griffin TJ; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA.
Publikováno v:
Proteomes [Proteomes] 2022 Apr 14; Vol. 10 (2). Date of Electronic Publication: 2022 Apr 14.
Autor:
Shuck S; Department of Diabetes and Cancer Metabolism, Beckman Research Institute of City of Hope, Duarte, California 91010, United States., Kalgutkar AS; Pfizer Worldwide Research, Development, and Medical Medicine Design, 610 Main Street, Cambridge, Massachusetts 02139, United States., Knutson CG; Pharmacokinetics Sciences, Novartis Institutes for BioMedical Research, 220 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States., Wang Y; Department of Chemistry, University of California Riverside, Riverside, California 92521, United States., Sturla SJ; Department of Health Sciences and Technology, ETH Zurich, 8092 Zurich, Switzerland.
Publikováno v:
Chemical research in toxicology [Chem Res Toxicol] 2022 Feb 21; Vol. 35 (2), pp. 111. Date of Electronic Publication: 2022 Jan 31.
Autor:
Hajal C; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Offeddu GS; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Shin Y; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Zhang S; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Morozova O; Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA, USA.; Amgen Research, Amgen Inc., Cambridge, MA, USA., Hickman D; Amgen Research, Amgen Inc., Cambridge, MA, USA., Knutson CG; Amgen Research, Amgen Inc., Cambridge, MA, USA., Kamm RD; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. rdkamm@mit.edu.; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. rdkamm@mit.edu.
Publikováno v:
Nature protocols [Nat Protoc] 2022 Jan; Vol. 17 (1), pp. 95-128. Date of Electronic Publication: 2022 Jan 07.
Autor:
Li N; Department of Pharmacokinetics and Drug Metabolism, Amgen Research, Amgen Inc, Cambridge, MA 02142, USA., Kulkarni P; Department of Pharmacokinetics and Drug Metabolism, Amgen Research, Amgen Inc, Cambridge, MA 02142, USA., Badrinarayanan A; Department of Pharmacokinetics and Drug Metabolism, Amgen Research, Amgen Inc, Cambridge, MA 02142, USA., Kefelegn A; Department of Pharmacokinetics and Drug Metabolism, Amgen Research, Amgen Inc, Cambridge, MA 02142, USA., Manoukian R; Department of Cytometry Sciences, Amgen Research, Amgen Inc, Cambridge, MA 02142, USA., Li X; Department of Pharmacokinetics and Drug Metabolism, Amgen Research, Amgen Inc, Cambridge, MA 02142, USA., Prasad B; Department of Pharmaceutical Sciences, Washington State University, Spokane, WA 99202, USA., Karasu M; Department of Pharmaceutical Sciences, Washington State University, Spokane, WA 99202, USA., McCarty WJ; Department of Pharmacokinetics and Drug Metabolism, Amgen Research, Amgen Inc, Cambridge, MA 02142, USA., Knutson CG; Department of Pharmacokinetics and Drug Metabolism, Amgen Research, Amgen Inc, Cambridge, MA 02142, USA., Gupta A; Department of Pharmacokinetics and Drug Metabolism, Amgen Research, Amgen Inc, Cambridge, MA 02142, USA. Electronic address: agupta.pharmaceuticals@gmail.com.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2021 Jan; Vol. 110 (1), pp. 325-337. Date of Electronic Publication: 2020 Sep 15.